256.56
Bio Rad Laboratories Inc stock is traded at $256.56, with a volume of 1.06M.
It is down -12.26% in the last 24 hours and down -20.37% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$292.42
Open:
$251
24h Volume:
1.06M
Relative Volume:
5.09
Market Cap:
$6.92B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-9.3875
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-14.91%
1M Performance:
-20.37%
6M Performance:
-10.66%
1Y Performance:
-16.26%
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BIO
Bio Rad Laboratories Inc
|
256.56 | 7.89B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus
Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat
Bio-Rad Laboratories Inc (BIO) Shares Down 11.17% on Feb 13 - GuruFocus
Oversold Conditions For Bio-Rad Laboratories (BIO) - Nasdaq
Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA - Nasdaq
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
S&P 500 Futures Drop in Premarket Trading; Pinterest, Bio-Rad Labs A Lag - Barron's
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView
Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus
Bio-Rad Laboratories, Inc. $BIO Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements - MSN
Bio-Rad Laboratories Q4 2025 Earnings Call Transcript - MarketBeat
Bio-Rad Laboratories Q4 Earnings Call Highlights - Yahoo Finance
Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts By Investing.com - Investing.com South Africa
Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results - MarketBeat
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript - AOL.com
Bio-Rad: Q4 Earnings Snapshot - kare11.com
BIO: 2025 results met guidance with diagnostics growth, ddPCR momentum, and cautious 2026 outlook - TradingView
BIO: 2025 saw resilient revenue and cash flow, with diagnostics growth and ddPCR momentum offsetting margin pressures - TradingView
Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations - Investing.com India
Bio-Rad: Fourth Quarter Financial Highlights - Bitget
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates - Yahoo Finance UK
Bio-Rad Laboratories Swings To Q4 Profit - Nasdaq
Bio-Rad shares tumble as Q4 earnings miss expectations By Investing.com - Investing.com Australia
Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results - TipRanks
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M - marketscreener.com
Bio-Rad Laboratories (NYSE:BIO) Announces Quarterly Earnings Results - MarketBeat
Is Bio Rad Laboratories Inc. stock risky to hold now2025 Analyst Calls & Verified Momentum Watchlists - mfd.ru
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - Business Wire
Bio-Rad earnings on deck as estimates drift lower ahead of report By Investing.com - Investing.com South Africa
Bio-Rad earnings on deck as estimates drift lower ahead of report - Investing.com UK
Can Bio Rad Laboratories Inc. (BUW) stock sustain revenue momentumTrade Risk Summary & Daily Oversold Stock Bounce Ideas - mfd.ru
Dematic Automation Solution Drives Precision and Productivity for BIO-RAD Singapore - iTWire
Bio-Rad receives AOAC international validation for EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Medical Biosensors Market is expected to reach US$ 12.60 Billion - openPR.com
Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad EZ-Check Listeria Test Kits Receive AOAC Validation - Food Safety Magazine
Multiplex Immunoassays Market to Reach US$ 6.90 Billion by 2033 - openPR.com
Atlantic Union Bankshares Corp Purchases Shares of 4,099 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday - MarketBeat
The Latest in ddPCR Technology - the-scientist.com
PCR Technologies Market Is Going to Boom |• Thermo Fisher Scientific • Bio-Rad Laboratories - openPR.com
Polymerase Chain Reaction Market Set for Rapid Growth and Trend - openPR.com
United States Digital PCR Market to Reach at 7.4% CAGR by 2031; - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Mawer Investment Management Ltd. Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Veritas Asset Management LLP Has $236.66 Million Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):